Figure 2.
Figure 2. FBXL5 deficiency is associated with poor survival of DEN-injected mice. (A) Survival rate of DEN-injected Fbxl5F/F (n = 44), Alb-Cre/Fbxl5F/F (n = 48), or Fbxl5−/−Irp2−/− (n = 55) male mice. ***, P < 0.005 (log-rank test). (B) Survival rate of DEN-injected Fbxl5F/F (n = 41), Alb-Cre/Fbxl5F/F (n = 62), or Fbxl5−/−Irp2−/− (n = 38) female mice. ***, P < 0.005 (log-rank test).

FBXL5 deficiency is associated with poor survival of DEN-injected mice. (A) Survival rate of DEN-injected Fbxl5F/F (n = 44), Alb-Cre/Fbxl5F/F (n = 48), or Fbxl5−/−Irp2−/− (n = 55) male mice. ***, P < 0.005 (log-rank test). (B) Survival rate of DEN-injected Fbxl5F/F (n = 41), Alb-Cre/Fbxl5F/F (n = 62), or Fbxl5−/−Irp2−/− (n = 38) female mice. ***, P < 0.005 (log-rank test).

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal